23.20

1.28% -0.30

Pharvaris Nv (PHVS)

Overview News Price History Discussions Forecast

Pharvaris Nv stock is traded at $23.20, with a volume of 55,526. It is down -1.28% in the last 24 hours and up +10.00% over the past month. Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Previous Close:

$23.50

Open:

$23.53

24h Volume:

55,526

Relative Volume:

0.52

Market Cap:

$1.49B

Revenue:

Net Income/Loss:

$-143.59M

P/E Ratio:

-8.2165

EPS:

-2.8236

Net Cash Flow:

$-119.47M

1W Performance:

+0.65%

1M Performance:

+10.00%

6M Performance:

+44.91%

1Y Performance:

+13.06%

1-Day Range:

$23.20

$23.73

1-Week Range:

$21.50

$24.83

52-Week Range:

$11.51

$26.33

Pharvaris Nv Stock (PHVS) Company Profile

Name

Pharvaris Nv

Sector

Healthcare (1152)

Industry

Biotechnology (648)

Phone

Address

Employee

114

Twitter

Next Earnings Date

2025-08-08

Latest SEC Filings

PHVS's Discussions on Twitter

Compare PHVS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PHVS Pharvaris Nv	23.20	1.49B	0	-143.59M	-119.47M	-2.8236
VRTX Vertex Pharmaceuticals Inc	394.53	99.62B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	465.89	61.52B	2.46B	-319.09M	-52.09M	-2.47
REGN Regeneron Pharmaceuticals Inc	560.00	58.91B	14.21B	4.46B	3.56B	39.68
ARGX Argen X Se Adr	756.38	46.69B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	324.34	34.54B	3.81B	-644.79M	-669.77M	-6.24

Pharvaris Nv Stock (PHVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-11-25	Initiated	Guggenheim	Buy
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight
Sep-25-23	Initiated	Wedbush	Outperform
Aug-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Oct-05-22	Initiated	Bryan Garnier	Buy
Sep-13-22	Resumed	JMP Securities	Mkt Outperform
Aug-23-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-22-22	Downgrade	BofA Securities	Neutral → Underperform
May-25-22	Initiated	JMP Securities	Mkt Outperform
Mar-02-21	Initiated	BofA Securities	Neutral
Mar-02-21	Initiated	Morgan Stanley	Overweight
Mar-02-21	Initiated	Oppenheimer	Outperform
Mar-02-21	Initiated	SVB Leerink	Outperform

View All

Pharvaris Nv (PHVS)

Pharvaris Nv Stock (PHVS) Company Profile

Compare PHVS with other stocks

Pharvaris Nv Stock (PHVS) Upgrades & Downgrades

Pharvaris Nv Stock (PHVS) Latest News

Is it too late to sell Pharvaris N.V.Quarterly Trade Review & Capital Efficient Trade Techniques - Newser

Will Pharvaris N.V. price bounce be sustainableEarnings Performance Report & Growth-Oriented Investment Plans - Newser

What moving averages say about Pharvaris N.V.July 2025 Big Picture & Weekly Market Pulse Updates - Newser

Detecting support and resistance levels for Pharvaris N.V.Quarterly Profit Review & Low Risk High Win Rate Stock Picks - Newser

Is Pharvaris N.V. a candidate for recovery playJuly 2025 Intraday Action & Fast Gain Stock Tips - Newser

How to recover losses in Pharvaris N.V. stockJuly 2025 Trends & Short-Term Swing Trade Alerts - Newser

Using fundamentals and technicals on Pharvaris N.V.Market Risk Summary & Technical Pattern Based Signals - Newser

Institutional scanner results for Pharvaris N.V.Oil Prices & Accurate Technical Buy Alerts - Newser

Pharvaris N.V. stock trend forecastDividend Hike & Reliable Trade Execution Plans - Newser

Is Pharvaris N.V. stock poised for growthWeekly Gains Summary & Community Verified Swing Trade Signals - Newser

Is Pharvaris N.V. still worth holding after the dip2025 Price Targets & Verified Chart Pattern Trade Signals - Newser

Should you hold or exit Pharvaris N.V. nowWeekly Trend Recap & Consistent Profit Alerts - Newser

Earnings visualization tools for Pharvaris N.V.Bull Run & Safe Capital Growth Stock Tips - Newser

Evaluating Pharvaris N.V. with trendline analysisJuly 2025 Volume & Free Community Consensus Stock Picks - Newser

Sector ETF performance correlation with Pharvaris N.V.Breakout Watch & Verified Technical Trade Signals - Newser

Pharvaris (NASDAQ:PHVS) Shares Up 8.3%Still a Buy? - MarketBeat

Pharvaris Secures Registration Rights Agreement with General Atlantic - MSN

Exit strategy if you’re trapped in Pharvaris N.V.Analyst Downgrade & Stepwise Entry and Exit Trade Signals - Newser

Is Pharvaris N.V. stock bottoming outBuy Signal & Comprehensive Market Scan Insights - Newser

What candlestick patterns are forming on Pharvaris N.V.July 2025 Breakouts & Free Community Consensus Stock Picks - Newser

Will Pharvaris N.V. see short term momentumQuarterly Trade Review & Free Low Drawdown Momentum Trade Ideas - Newser

how to recover losses in pharvaris n.v. stockQuarterly Earnings Summary & Detailed Earnings Play Strategies - Newser

Does Pharvaris N.V. qualify in momentum factor screeningJuly 2025 Fed Impact & Daily Chart Pattern Signal Reports - Newser

What technical models suggest about Pharvaris N.V.’s comebackDay Trade & Low Risk Investment Opportunities - Newser

What institutional flow reveals about Pharvaris N.V.Dip Buying & Smart Allocation Stock Reports - Newser

Measuring Pharvaris N.V.’s beta against major indicesDividend Hike & Technical Buy Zone Confirmation - Newser

How to monitor Pharvaris N.V. with trend dashboardsEarnings Overview Summary & Safe Entry Trade Signal Reports - Newser

Pharvaris N.V. Hits Oversold Level on RSI IndicatorPortfolio Value Report & Accurate Intraday Trade Tips - beatles.ru

Short Interest Drops in Pharvaris N.V. After RallyJuly 2025 Catalysts & Reliable Volume Spike Alerts - beatles.ru

Pharvaris Nv Stock (PHVS) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to PHVS